- This event has passed.
SATA East Regional Meeting
April 23 @ 8:25 am - 12:45 pm
SATA Regional Meeting Announcement
DMV Liver Transplant Anesthesia Meeting 2022
Meeting: DMV Liver Transplant Anesthesia Meeting 2022
Date: Saturday, April 23rd, 2022
Time: 8:25 AM – 12:45 PM (ET)
Venue: Zoom Virtual
Lorenzo De Marchi, MD, FASE (MedStar-Georgetown University Hospital)
Completed Program, Registration Information, and CME fee schedule will be sent to you soon.
Live Virtual Conference (Zoom meeting)
This SATA regional meeting provides the audience with updated knowledge on several critical management issues in the liver transplant patients population.
- Discuss post operative pain management of the donor in a living donor liver transplant (LDLT).
- Discuss the management of post reperfusion coagulopathy and choice of vasoactive drugs during orthotopic liver transplantation (OLT).
- Review the pathophysiology and the impact of Cirrhotic Cardiomyopathy and Sickle Cell disease in the liver transplant population.
- Discuss the surgical criteria for matching candidates to liver transplant and graft.
- Share the clinical experience in challenging OLT cases.
- Debate the pros and cons of having a dedicated ICU for liver transplant patients.
Specialists working in the area of organ transplantation (ex., transplant anesthesiologists, intensivists, transplant surgeons, other transplant medicine specialists, and CRNAs); Trainees (ex., residents, fellows); Students (medical students, nursing students)
Accreditation and CME credit designation:
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and SATA. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh Medical Center designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™ will be available. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To claim your CME: http://cce.upmc.com
Program committee members:
- Lorenzo De Marchi, MD, FASE (MedStar-Georgetown University Hospital)
- Aliaksei Pustavoitau, MD (Johns Hopkins Hospital)
- Katherine Forkin, MD (UVA University Hospital)
- Spencer Liebman, MD (VCU Medical Center)
- Sergio Navarrete, MD (Johns Hopkins Hospital)
- Tetsuro Sakai, MD, PhD, MHA (UPMC Medical Center
Platform: Zoom Webinar (address and password will be provided at the time of registration)
- For CME Credit: $30
- Free if:
- you are trainees, medical students, or national/international medical personals who do not need CME credits.
- lecturers and moderators of the meeting.
8:25-8:30am Welcome and Introduction
Lorenzo De Marchi, MD (MGUH)
8:30-9:30am Session 1: Perioperative Anesthesia
Moderator: Spencer Liebman, MD (VCU)
LDLT Pain management (Donor)
John Burgner, MD (VCU)
Post Reperfusion Coagulopathy
Julie Huffmyer, MD (UVA)
What vasoactive drug(s) to use during OLT
Aliaksei Pustavoitau, MD (JHH)
9:30-9:40am Coffee Break
9:40-10:40am Session 2: Multidisciplinary session
Moderator: Sergio Navarrete, MD (JHH)
Ilan Wittstein, MD (JHH)
Patient-graft match UVA
Shawn Pelletier, MD (UVA)
OLT in Sickle Cell patients
Ahmet Gurakar (JHH)
10:45-11:30am Challenging Clinical Cases
Moderator: Katherine Forkin, MD (UVA)
Takotsubo Cardiomyopathy, failure is around the corner
Sam Lawrence, MD (MGUH)
Eryn Thiele, MD (UVA)
OLT in a patient with an acute traumatic intracerebral hemorrhage
Beau Billadeau, MD (VCU)
11:30-12:30pm PRO/CON Debate: Should we add a “T” before ICU?
Moderator: Aliaksei Pustavoitau, MD (JHH)
PRO: We need a dedicated Transplant ICU
Megan Rashid, MD (VCU)
CON: We do NOT need a dedicated Transplant ICU
Benjamin Philosophe, MD (JHH)
12:30-12:45pm Closing remarks
Tetsuro Sakai, MD, PhD, MHA, FASA (President, SATA)
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated:
- Tetsuro Sakai, MD, PhD, MHA: Springer Inc. (Book royalty), Haemonetics Inc (Grant/Research Support)
- Aliaksei Pustavoitau, MD: Equity ownership in CoapTech; Stock ownership in GE, Butterfly Network, Sana Biotechnology, Moderna, AstraZeneca, eHealth, and Atea Pharmaceuticals
- Megan Rashid, MD: Baxter Brazil (Lecturer)
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
The information presented at this CME program represents the views and opinions of the individual presenters. It does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been made to prepare the educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use their own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions, including, without limitation, FDA-approved uses and any off-label uses.